- Michael Peel and Antonia Cundy: The cowboy clinics selling unproven longevity treatments. Wherein two FT reportes pose as patients and get to hear some ridiculous promises. How on Earth do these supposed doctors get to keep their licenses?
- Robert Armstrong: The US consumer is showing some strain. Great data analysis work. If only people gave that much scrutiny to biomedcial research.
- Miranda Green: Have you got 10 minutes? No? Neither do I.
- Madhumita Murgia: Anthropic launches AI tool that can conduct scientific experiments. As if science wasn’t slop-ridden already. Says the text:
AI has become increasingly important to drug research at big pharmaceutical companies. Eli Lilly, maker of popular weight-loss drugs, has partnered with AI chipmaker Nvidia chips and earlier this year invested in Insilico Medicine, a company focused on AI for drug discovery.
Please. I would wait until any of the money poured into drug discovery AI produces a tangible result before calling it “increasingly important”. Never mind that it’s not the discovery that is the real bottleneck.